BACTRIM

This brand name is authorized in Brazil, Ecuador, Estonia, France, Malta, Mexico, Poland, Tunisia, Turkey, United States, South Africa

Active ingredients

The drug BACTRIM contains a combination of these active pharmaceutical ingredients (APIs):

1 Sulfamethoxazole UNII JE42381TNV - SULFAMETHOXAZOLE

Sulfamethoxazole competitively inhibits the utilisation of para-aminobenzoic acid in the synthesis of dihydrofolate by the bacterial cell resulting in bacteriostasis. Read about Sulfamethoxazole

2 Trimethoprim UNII AN164J8Y0X - TRIMETHOPRIM

Trimethoprim is a dihydrofolate reductase inhibitor, inhibiting the conversion of bacterial dihydrofolic acid to tetrahydrofolic acid, required for the synthesis of some amino acids. Its effects are considerably greater on the cells of micro-organisms than on the mammalian cells. Read about Trimethoprim

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BACTRIM DS Tablet	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01EE01	Sulfamethoxazole and trimethoprim	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01E Sulfonamides and trimethoprim → J01EE Combinations of sulfonamides and trimethoprim, incl. derivatives
Discover more medicines within J01EE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 509020090023517, 509020090023617, 509020090023717, 509020090023817
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 29499-1-11-10, 29526-1-12-10, 6765-MEE-1121, 6812-MEE-1221
Country: EE	Ravimiamet	Identifier(s): 1008818, 1158948, 1793066, 1816545, 1817580, 1846212, 1853243
Country: FR	Base de données publique des médicaments	Identifier(s): 64121235, 65181349, 65880598, 69233327
Country: MT	Medicines Authority	Identifier(s): AA565/63801
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 145M79, 73349, 73362
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100008671, 100008688, 100008694, 100241568, 100241597, 100241605, 100241657, 100272072, 100274444, 100299585, 100326595, 100327637, 100354500, 100366672, 100391121, 100406450, 100407916, 100463698, 100466850, 100467032
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 9253081, 9253082, 9253083
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699525094636, 8699525094643, 8699525284624, 8699525754615
Country: US	FDA, National Drug Code	Identifier(s): 49708-145, 49708-146, 80425-0001, 80425-0002, 80425-0003
Country: ZA	Health Products Regulatory Authority	Identifier(s): B/20.2/111, F/20.2/191, L/20.2/0064